ProfileGDS4459 / ENSG00000134744
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 86% 88% 89% 87% 88% 87% 82% 89% 88% 86% 86% 86% 88% 84% 85% 85% 87% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 16.5986
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 26.7788
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 37.1989
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 46.687
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 57.1188
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 66.9287
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 76.3882
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 87.2489
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 97.0888
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 106.7686
GSM623474group B, liver allograft wedge biopsie placebo treatment 16.8786
GSM623475group B, liver allograft wedge biopsie placebo treatment 26.9286
GSM623476group B, liver allograft wedge biopsie placebo treatment 37.0688
GSM623477group B, liver allograft wedge biopsie placebo treatment 46.2484
GSM623478group B, liver allograft wedge biopsie placebo treatment 56.7985
GSM623479group B, liver allograft wedge biopsie placebo treatment 66.4585
GSM623480group B, liver allograft wedge biopsie placebo treatment 76.7787